The role of anti-inflammatory agents in age-related macular degeneration (AMD) treatment
- 24 December 2010
- journal article
- Published by Springer Science and Business Media LLC in Eye
- Vol. 25 (2), 127-139
- https://doi.org/10.1038/eye.2010.196
Abstract
No abstract availableThis publication has 103 references indexed in Scilit:
- A RANDOMIZED PILOT STUDY OF SYSTEMIC IMMUNOSUPPRESSION IN THE TREATMENT OF AGE-RELATED MACULAR DEGENERATION WITH CHOROIDAL NEOVASCULARIZATIONRetina, 2010
- Low-Dose Aspirin and Medical Record–Confirmed Age-related Macular Degeneration in a Randomized Trial of WomenOphthalmology, 2009
- Molecular pathology of age-related macular degenerationProgress in Retinal and Eye Research, 2009
- Age-related macular degenerationThe Lancet, 2008
- Immunopathological aspects of age-related macular degenerationSeminars in Immunopathology, 2008
- Gene-environment interaction in progression of AMD: the CFH gene, smoking and exposure to chronic infectionHuman Molecular Genetics, 2008
- Complement-targeted therapeuticsNature Biotechnology, 2007
- The role of complement system in ocular diseases including uveitis and macular degenerationMolecular Immunology, 2007
- Complement Factor H Polymorphism in Age-Related Macular DegenerationScience, 2005
- The Prevalence of Age-Related Macular Degeneration and Associated Risk FactorsJAMA Ophthalmology, 2001